Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
105 hedge funds and large institutions have $765M invested in Myovant Sciences Ltd. in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 32 increasing their positions, 31 reducing their positions, and 22 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
73% more capital invested
Capital invested by funds: $441M → $765M (+$324M)
18% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 22
3% more funds holding
Funds holding: 102 → 105 (+3)
3% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 31
11% less call options, than puts
Call options by funds: $23.4M | Put options by funds: $26.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$29.6M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$22.1M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$8.14M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.53M |
| 5 |
Morgan Stanley
New York
|
+$2.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$26M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$8.47M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$6.84M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$5.61M |
| 5 |
O
OrbiMed
New York
|
-$5.12M |
MYOV Hedge Fund Activity: Q4 2020 in Review
105 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q4 2020, worth a combined $765M — up 73% from $441M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new MYOV positions and 22 closed out — a net gain of 4 holders — while 32 added to existing stakes and 31 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $29.6M. The largest seller was Fidelity Investments, cutting an estimated $26M.
- 105 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q4 2020, up from 102 in Q3 2020.
- Funds reported $765M of Myovant Sciences Ltd. stock for Q4 2020, up 73% quarter-over-quarter.
- 26 funds opened new Myovant Sciences Ltd. positions in Q4 2020 and 22 closed out, a net change of +4 holders.
- The largest Myovant Sciences Ltd. buyer in Q4 2020 was Wellington Management Group, an estimated $29.6M added.
- The largest Myovant Sciences Ltd. seller in Q4 2020 was Fidelity Investments, an estimated $26M sold.
Based on aggregated 13F filings for Q4 2020.